Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.75B |
| 2 |
Microsoft
MSFT
|
+$2.46B |
| 3 |
NVIDIA
NVDA
|
+$2.3B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.79B |
| 5 |
Amazon
AMZN
|
+$1.78B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$338M |
| 2 |
DAY
Dayforce
DAY
|
+$281M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$225M |
| 4 |
CYBR
CyberArk
CYBR
|
+$220M |
| 5 |
CMA
Comerica
CMA
|
+$213M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.41% |
| 2 | Financials | 12.78% |
| 3 | Consumer Discretionary | 9.97% |
| 4 | Healthcare | 9.79% |
| 5 | Communication Services | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Goosehead Insurance
GSHD
$1.47B
| $26M | ﹤0.01% |
608,872
-107,276
| -15% | -$6M |
|
1852
Wave Life Sciences
WVE
$1.14B
| $26M | ﹤0.01% |
3,579,099
+408,989
| +13% | +$5.33M |
|
|
XXI
1853
Twenty One Capital Inc
XXI
$1.57B
| $25.9M | ﹤0.01% |
+4,051,834
| New | +$29.7M |
|
1854
The RealReal
REAL
$1.4B
| $25.9M | ﹤0.01% |
2,852,047
+404,865
| +17% | +$5.12M |
|
1855
Allient
ALNT
$1.47B
| $25.9M | ﹤0.01% |
438,184
+69,698
| +19% | +$4.39M |
|
1856
Pacira BioSciences
PCRX
$1.04B
| $25.9M | ﹤0.01% |
1,143,820
-25,771
| -2% | -$573K |
|
1857
Old Second Bancorp
OSBC
$1.27B
| $25.9M | ﹤0.01% |
1,282,011
-83,437
| -6% | -$1.67M |
|
1858
CRA International
CRAI
$1.12B
| $25.8M | ﹤0.01% |
159,603
+4,708
| +3% | +$849K |
|
|
DEC
1859
Diversified Energy Company
DEC
$878M
| $25.8M | ﹤0.01% |
1,480,206
+727,836
| +97% | +$10.3M |
|
|
CSR
1860
Centerspace
CSR
$937M
| $25.8M | ﹤0.01% |
449,258
+12,062
| +3% | +$758K |
|
|
PMT
1861
PennyMac Mortgage Investment
PMT
$839M
| $25.8M | ﹤0.01% |
2,213,348
+100,163
| +5% | +$1.24M |
|
1862
MasterBrand
MBC
$1.12B
| $25.8M | ﹤0.01% |
3,098,501
+88,073
| +3% | +$952K |
|
1863
Pennant Group
PNTG
$1.44B
| $25.7M | ﹤0.01% |
842,138
+22,090
| +3% | +$683K |
|
|
PVLA
1864
Palvella Therapeutics
PVLA
$2.03B
| $25.6M | ﹤0.01% |
205,609
+26,617
| +15% | +$2.78M |
|
1865
EyePoint Inc
EYPT
$1.04B
| $25.6M | ﹤0.01% |
1,983,665
+84,298
| +4% | +$1.26M |
|
1866
Astrana Health
ASTH
$1.89B
| $25.5M | ﹤0.01% |
1,038,085
+9,917
| +1% | +$235K |
|
1867
OceanFirst Financial
OCFC
$1.7B
| $25.4M | ﹤0.01% |
1,410,048
-10,394
| -0.7% | -$191K |
|
1868
Worthington Steel
WS
$1.84B
| $25.4M | ﹤0.01% |
837,890
+62,694
| +8% | +$2.43M |
|
1869
Methanex
MEOH
$4.19B
| $25.4M | ﹤0.01% |
337,302
-19,080
| -5% | -$960K |
|
1870
Monte Rosa Therapeutics
GLUE
$1.91B
| $25.4M | ﹤0.01% |
1,540,812
+335,968
| +28% | +$6.42M |
|
1871
Enovix
ENVX
$923M
| $25.2M | ﹤0.01% |
4,872,090
+458,598
| +10% | +$2.87M |
|
1872
Tyra Biosciences
TYRA
$1.85B
| $25.2M | ﹤0.01% |
658,482
+726
| +0.1% | +$23.5K |
|
1873
Nuvation Bio
NUVB
$2.32B
| $25.2M | ﹤0.01% |
5,863,654
+151,358
| +3% | +$843K |
|
1874
Harmonic Inc
HLIT
$1.23B
| $25.1M | ﹤0.01% |
2,794,248
+58,599
| +2% | +$582K |
|
1875
Corvus Pharmaceuticals
CRVS
$1.09B
| $25.1M | ﹤0.01% |
1,712,741
+239,715
| +16% | +$3.83M |
|
Similar funds
Geode Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Geode Capital Management held 4,628 positions worth $1.61T, down 0.8% from $1.62T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Geode Capital Management deployed $55.8B of net new capital in Q1 2026, opening 160 new positions and adding to 3,465 existing holdings. Its largest new stake was Versant Media Group: 1,896,951 shares worth $70.3M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Hershey, an estimated $134M trimmed.
- Geode Capital Management's largest Q1 2026 buy was Versant Media Group: 1,896,951 shares worth $70.3M.
- Geode Capital Management added most to Apple in Q1 2026, an estimated $2.75B increase.
- Geode Capital Management's biggest Q1 2026 reduction was Hershey, cutting an estimated $134M.
- Geode Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $338M.
- Geode Capital Management's ten largest holdings make up 31% of its $1.61T portfolio in Q1 2026.
- Geode Capital Management opened 160 new positions and closed 115 in Q1 2026.
- Geode Capital Management's portfolio value fell 0.8% quarter-over-quarter to $1.61T.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.